AI assistant
NEOGENOMICS INC — Director's Dealing 2021
Mar 4, 2021
32227_dirs_2021-03-03_82d1ab11-0099-4bac-adde-ea87e5e9f474.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-03-01
Reporting Person: BALLIET JENNIFER (VP and Chief Culture Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-01 | Common Stock | F | 212 | — | Disposed | 24768 | Direct |
| 2021-03-02 | Common Stock | F | 173 | — | Disposed | 24595 | Direct |
| 2021-03-02 | Common Stock | A | 1862 | — | Acquired | 26457 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-02 | Stock Option (Right to Buy) | $53.17 | A | 10551 | Acquired | 2028-03-02 | Common Stock (10551.0) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $7.52 | 2022-04-28 | Common Stock (7000.0) | 7000 | Direct |
| Stock Option (Right to Buy) | $8.03 | 2023-02-26 | Common Stock (33334.0) | 33334 | Direct |
| Stock Option (Right to Buy) | $19.6 | 2024-03-01 | Common Stock (17496.0) | 17496 | Direct |
| Stock Option (Right to Buy) | $28.33 | 2027-03-02 | Common Stock (15006.0) | 15006 | Direct |
Footnotes
F1: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2021 vesting of restricted stock.
F2: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2021 vesting of restricted stock.
F3: On April 28, 2017, Ms. Balliet was granted 60,000 stock options. These options vested ratably over the first three anniversaries of the grant date.
F4: On February 26, 2018, Ms. Balliet was granted 72,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
F5: On March 1, 2019, Ms. Balliet was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F6: On March 2, 2020, Ms. Balliet was granted 15,006 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F7: On March 2, 2021, Ms. Balliet was granted 10,551 stock options. These options vest ratably over the first four anniversary dates of the grant date.